Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Savior Lifetec Corp (4167) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8123
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Savior Lifetec Corp (SLC) is an injectable manufacturer and distributor. The company offers active pharmaceutical ingredients (APIs) and finished dosage formulations. It provides sterile crystallization and aseptic processing of sterile powder. SLC offers carbapenem products, which include imipenem, meropenem, and ertapenem. The company’s imipenem and cilastatin injection are used in treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin and skin structure infections, endocarditis and polymicrobic infections. The company’s product pipeline consists various injections and subcutaneous injections. It operates offices in Zhunan and Tainan, Taiwan. SLC is headquartered in Zhunan, Taiwan.

Savior Lifetec Corp (4167) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Savior Lifetec Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Savior Lifetec Corp, Medical Devices Deals, 2012 to YTD 2018 9
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Savior Lifetec Raises USD2.2 Million in Public Offering of Shares 11
Savior Lifetec Raises USD16.6 Million in Rights Offering of Shares 12
Savior Lifetec Raises USD12.3 Million in IPO 13
Savior Lifetec Raises USD11 Million in Public Offering of Shares 14
Debt Offering 15
Savior Lifetec to Raise USD23 Million in Public Offering of Bonds 15
Savior Lifetec Corp – Key Competitors 16
Savior Lifetec Corp – Key Employees 17
Savior Lifetec Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Savior Lifetec Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Savior Lifetec Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Savior Lifetec Corp, Medical Devices Deals, 2012 to YTD 2018 9
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Savior Lifetec Raises USD2.2 Million in Public Offering of Shares 11
Savior Lifetec Raises USD16.6 Million in Rights Offering of Shares 12
Savior Lifetec Raises USD12.3 Million in IPO 13
Savior Lifetec Raises USD11 Million in Public Offering of Shares 14
Savior Lifetec to Raise USD23 Million in Public Offering of Bonds 15
Savior Lifetec Corp, Key Competitors 16
Savior Lifetec Corp, Key Employees 17
Savior Lifetec Corp, Other Locations 18

List of Figures
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Savior Lifetec Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Savior Lifetec Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New Gold Inc
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tullow Oil Plc (TLW):企業の財務・戦略的SWOT分析
    Tullow Oil Plc (TLW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Array BioPharma Inc (ARRY):製薬・医療:M&Aディール及び事業提携情報
    Summary Array BioPharma Inc (Array) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of targeted small-molecule drugs indicated for the treatment of cancer and inflammatory diseases. The company’s most advanced wholly-owned clinical stage drugs includ …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ICON Plc (ICLR):企業の財務・戦略的SWOT分析
    ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • OWC Pharmaceutical Research Corp (OWCP):製薬・医療:M&Aディール及び事業提携情報
    Summary OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual solubl …
  • NOWDiagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary NOWDiagnostics Inc (NOWDiagnostics) is a medical diagnostic company. The company manufactures and sells blood-based rapid tests. It offers acetaminophen test, hCG test, H-FABP test, methanol dip test, salicylate test, troponin I test, myoglobin test, in home HIV test, and others. NOWDiagnost …
  • Mitsubishi Tanabe Pharma Corp (4508):企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Martin Marietta Materials Inc:企業のM&A・事業提携・投資動向
    Martin Marietta Materials Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Marietta Materials Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Taris Biomedical LLC:企業のM&A・事業提携・投資動向
    Taris Biomedical LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taris Biomedical LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Honeywell International Inc (HON):石油・ガス:M&Aディール及び事業提携情報
    Summary Honeywell International Inc. (Honeywell) is a diversified manufacturing and technology company. The company offers avionics, aircraft engines, systems and service solutions; environmental and combustion controls, sensing controls, security and life safety products and services, scanning and …
  • Altadis USA Inc:企業の戦略・SWOT・財務情報
    Altadis USA Inc - Strategy, SWOT and Corporate Finance Report Summary Altadis USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Scientex Bhd (SCIENTX):企業の財務・戦略的SWOT分析
    Summary Scientex Bhd (Scientex) is a manufacturer and supplier of packaging products and component parts for automotive interior. The company operates through stretch and custom film, converting, specialty products and property development divisions. It offers lamination base, general, barrier and a …
  • China New Borun Corporation:企業の戦略・SWOT・財務分析
    China New Borun Corporation - Strategy, SWOT and Corporate Finance Report Summary China New Borun Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Adris grupa dd:企業の戦略・SWOT・財務分析
    Adris grupa dd - Strategy, SWOT and Corporate Finance Report Summary Adris grupa dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • Par Pacific Holdings Inc (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings Inc (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆